PUNE: A study carried out to assess Omicron's immune-escape ability has found that it's better at resisting Covaxin than the original SARS-CoV-2 B.1 (Wuhan) variant, and the Beta and Delta variants. The research was carried out by experts from the Pune-based ICMR-National Institute of Virology (NIV).
Researchers studied Omicron's response to serum samples from three groups of people: ones who never had Covid but received two doses of Covaxin; ones given two jabs after recovery; and finally, breakthrough cases - individuals who contracted Covid after two jabs of Covaxin.
